Literature DB >> 15164415

A novel PCR approach for prenatal detection of the common NEMO rearrangement in incontinentia pigmenti.

Julie Steffann1, Valérie Raclin, Asmae Smahi, Hayley Woffendin, Arnold Munnich, Sue J Kenwrick, Anne-Gaelle Grebille, Alexandra Benachi, Yves Dumez, Jean-Paul Bonnefont, Smaïl Hadj-Rabia.   

Abstract

OBJECTIVES: Incontinentia pigmenti (IP) is a rare X-linked dominant genodermatosis that is usually lethal in males in the prenatal period. Largely 80% of cases are accounted for by a large-scale deletion encompassing exons 4 to 10 of the NEMO gene. The aim of this work was to facilitate prenatal diagnosis of IP by devising a novel test for detection of the prevalent NEMO deletion.
METHODS: We devised a sensitive and reproducible multiplex PCR test enabling simultaneous amplification of the deleted and wild-type NEMO genes in IP female individuals.
RESULTS: Combination of this DNA test, with Xq28 linkage analysis and X-inactivation pattern study enabled us to offer an IP prenatal diagnosis in 15 of the 16 couples at a 50% risk to have an affected offspring.
CONCLUSION: A current approach to IP prenatal diagnosis is proposed on the basis of the previously mentioned molecular tools. Copyright 2004 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15164415     DOI: 10.1002/pd.889

Source DB:  PubMed          Journal:  Prenat Diagn        ISSN: 0197-3851            Impact factor:   3.050


  8 in total

1.  Clinical Utility Gene Card for: incontinentia pigmenti.

Authors:  Francesca Fusco; Alessandra Pescatore; Julie Steffann; Ghislaine Royer; Jean-Paul Bonnefont; Matilde Valeria Ursini
Journal:  Eur J Hum Genet       Date:  2012-10-10       Impact factor: 4.246

2.  Rescue of recurrent deep intronic mutation underlying cell type-dependent quantitative NEMO deficiency.

Authors:  Bertrand Boisson; Yoshitaka Honda; Masahiko Ajiro; Jacinta Bustamante; Matthieu Bendavid; Andrew R Gennery; Yuri Kawasaki; Jose Ichishima; Mitsujiro Osawa; Hiroshi Nihira; Takeshi Shiba; Takayuki Tanaka; Maya Chrabieh; Benedetta Bigio; Hong Hur; Yuval Itan; Yupu Liang; Satoshi Okada; Kazushi Izawa; Ryuta Nishikomori; Osamu Ohara; Toshio Heike; Laurent Abel; Anne Puel; Megumu K Saito; Jean-Laurent Casanova; Masatoshi Hagiwara; Takahiro Yasumi
Journal:  J Clin Invest       Date:  2018-12-18       Impact factor: 14.808

3.  A case of incontinentia pigmenti in Japan and its genetic examination.

Authors:  Jane Huang; Hiroyuki Kondo; Eiichi Uchio
Journal:  Jpn J Ophthalmol       Date:  2007-04-06       Impact factor: 2.447

4.  The common NF-κB essential modulator (NEMO) gene rearrangement in Korean patients with incontinentia pigmenti.

Authors:  Min-Jung Song; Jong-Hee Chae; Eun-Ae Park; Chang-Seok Ki
Journal:  J Korean Med Sci       Date:  2010-09-20       Impact factor: 2.153

5.  Incontinentia pigmenti in a newborn with NEMO mutation.

Authors:  Young Lee; Sooyeon Kim; Kyunghee Kim; Meayoung Chang
Journal:  J Korean Med Sci       Date:  2011-01-24       Impact factor: 2.153

6.  Utility of molecular studies in incontinentia pigmenti patients.

Authors:  Seema Thakur; Ratna D Puri; Sudha Kohli; Renu Saxena; I C Verma
Journal:  Indian J Med Res       Date:  2011-04       Impact factor: 2.375

7.  Pulmonary hypertension and vasculopathy in incontinentia pigmenti: a case report.

Authors:  Abduljabbar Alshenqiti; Marwan Nashabat; Hissah AlGhoraibi; Omar Tamimi; Majid Alfadhel
Journal:  Ther Clin Risk Manag       Date:  2017-05-09       Impact factor: 2.423

8.  Challenges in Rare Diseases Diagnostics: Incontinentia Pigmenti with Heterozygous GBA Mutation.

Authors:  Snežana Minić; Dušan Trpinac; Ivana Novaković; Nataša Cerovac; Danijela Dobrosavljević Vukojević; Jérémie Rosain
Journal:  Diagnostics (Basel)       Date:  2022-07-14
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.